A clot-dissolving medication produced using recombinant DNA technology, used to dissolve blood clots in conditions such as ischemic stroke, pulmonary embolism, or myocardial infarction.
Recombinant tissue plasminogen activator (rtPA)
Haberi Paylaş
15/08/2024
